An employee of the German biopharmaceutical company CureVac demonstrates research workflow on a vaccine for the coronavirus.
ANDREAS GEBERT/ REUTERS
An employee of the German biopharmaceutical company CureVac demonstrates research workflow on a vaccine for the coronavirus.
ANDREAS GEBERT/ REUTERS